Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Effects of Gaze Stabilization Exercises and Optokinetic Training in Peripheral Vestibular Disorders

3. juli 2026 oppdatert av: Foundation University Islamabad
This study compares the effectiveness of Gaze Stabilization Exercises and Optokinetic Training in improving dizziness, balance, and confidence in individuals with peripheral vestibular disorders.

Studieoversikt

Detaljert beskrivelse

Peripheral vestibular disorders (PVD) commonly cause dizziness, postural instability, and decreased balance confidence, which increase the risk of falls and limit participation in daily activities. Vestibular rehabilitation is widely used to manage these symptoms. Among rehabilitation approaches, Gaze Stabilization Exercises (GSE) aim to improve vestibulo-ocular reflex function, while Optokinetic Training (OKT) promotes symptom habituation through visual motion stimulation. However, the comparative effectiveness of these two interventions remains unclear.

This study aims to compare the effects of GSE and OKT on dizziness severity, postural stability, and balance confidence in individuals with peripheral vestibular disorders. Participants will undergo intervention sessions three times per week for six weeks. Outcome measures will be assessed at baseline, mid-intervention (week 3), and post-intervention (week 6).

Primary and secondary outcomes will include the Dizziness Handicap Inventory (DHI), Dynamic Gait Index (DGI), and the Activities-specific Balance Confidence (ABC) Scale. Data will be analyzed using SPSS statistical software. It is hypothesized that both interventions will improve dizziness, balance, and confidence, though differences in effectiveness may exist between the two approaches.

The findings of this study are expected to contribute to evidence-based vestibular rehabilitation by identifying effective intervention strategies. The results may help clinicians design personalized rehabilitation programs aimed at reducing fall risk, improving functional mobility, and enhancing quality of life in individuals with peripheral vestibular disorders.

Studietype

Intervensjonell

Registrering (Faktiske)

32

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Islamabad, Pakistan, 44000
        • Foundation University College of Physical Therapy

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen

Tar imot friske frivillige

Nei

Beskrivelse

Inclusion Criteria:

  • Male and female patients aged 35-55 years
  • Complaining of dizziness for at least three months
  • Reporting at least one dizziness episode per month
  • Medical diagnosis of chronic peripheral vestibular disease
  • Willingness to participate and provide informed consent

Exclusion Criteria:

  • Medical history or signs of central nervous system disorders and/or psychiatric disorders
  • Uncontrolled hypertension and diabetes
  • Incapacity to understand and follow simple verbal commands
  • Inability to independently remain in standing position
  • Severe visual impairment or visual impairment not compensated by corrective lenses
  • Orthopedic disorders resulting in movement limitation or use of lower-limb prostheses
  • Previous body balance rehabilitation in the last six months

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Gaze Stabilization Exercises

Purpose:

Enhance gaze stability, postural control, and confidence in functional activities.

Description:

Week 1: Sitting, VOR x1 horizontal, fixate on near target - start gaze stability.

Week 2: Sitting, VOR x1 vertical, near/far target - increase head speed. Week 3: Standing, VOR x1 horizontal, fixate on target - improve upright balance.

Week 4: Standing, VOR x1 with busy background - challenge visual-vestibular interaction.

Week 5: Standing, VOR x2 horizontal/vertical - advanced gaze stabilization. Week 6: Standing, VOR x2 with busy background - integrate dynamic visual input.

The control group received gaze stabilization exercises for 6 weeks, comprising 18 supervised sessions conducted three times weekly. Training included VOR x1 and VOR x2 exercises in horizontal and vertical planes using near and far visual targets. Exercises progressed from sitting to standing positions and from simple to visually busy backgrounds. Each session also included balance training activities such as weight shifts, tandem stance, pivot turns, and walking with head movements, with rest periods provided as needed.
Aktiv komparator: Optokinetic Training

Purpose:

Reduce visually induced dizziness, enhance balance, and improve confidence in daily activities.

Description:

Week 1: Horizontal stripes Week 2: Vertical motion Week 3: Real-world videos Week 4: Crowded/busy scenes Week 5: Moving environment + light movement Week 6: Provocative videos (spirals/crowded)

The experimental group underwent optokinetic training for 6 weeks with 18 supervised sessions conducted three times weekly. Participants were exposed to progressively challenging moving visual stimuli, including distortion patterns, busy street scenes, motorway driving videos, and chequerboard jiggle/wrap patterns. Training advanced from sitting to standing with dynamic movements as visual complexity increased. Baseline and task-specific balance exercises were incorporated into every session, with adequate rest periods provided when necessary.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Dizziness
Tidsramme: 6 weeks

It will be measured by using Dizziness Handicap Inventory.

Score Interpretation:

0-30: Slight or Mild Handicap 31-60: Moderate Handicap 61-100: Severe Handicap

6 weeks
Postural Stability
Tidsramme: 6 weeks

It will be measured by using Dynamic Gait Index (DGI).

Interpretation:

≤19 = increased fall risk 20-24 = safe ambulation Higher scores = better gait performance and dynamic balance Lower scores = impaired gait and higher fall risk

6 weeks
Balance Confidence
Tidsramme: 6 weeks

It will be measured by using Activities-specific Balance Confidence (ABC) Scale.

Interpretation:

<50% = low level of physical functioning and high fall risk 50-80% = moderate level of functioning80% = high level of functioning and confidence Higher scores = greater balance confidence Lower scores = fear of falling and reduced functional independence

6 weeks

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

18. november 2025

Primær fullføring (Faktiske)

1. mai 2026

Studiet fullført (Faktiske)

1. mai 2026

Datoer for studieregistrering

Først innsendt

7. mai 2026

Først innsendt som oppfylte QC-kriteriene

7. mai 2026

Først lagt ut (Faktiske)

13. mai 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

7. juli 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

3. juli 2026

Sist bekreftet

1. juli 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • FUI/FUCP/CTR/Neuro1/AqsaKhalil

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere